• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[胶质母细胞瘤]

[Glioblastoma].

作者信息

Martin D H, Bianchi E, Ben Mustapha S, Frères P

机构信息

Service de Neurochirurgie, CHU Liège, Belgique.

Service d'Anatomie et Cytologie pathologiques, CHU Liège, Belgique.

出版信息

Rev Med Liege. 2021 May;76(5-6):419-424.

PMID:34080374
Abstract

Glioblastoma is the most common primary malignant brain tumor. Despite treatments combining excisional surgery, chemotherapy, and radiotherapy, overall survival remains low and the incidence of tumor recurrence remains high. Advances in the understanding of the disease, particularly its molecular biology and the mechanisms of action of systemic and radiotherapeutic treatments, as well as the development of image-guided surgical techniques, offer hope for the control of this hitherto incurable disease.

摘要

胶质母细胞瘤是最常见的原发性恶性脑肿瘤。尽管采用了手术切除、化疗和放疗相结合的治疗方法,但总体生存率仍然很低,肿瘤复发率仍然很高。对该疾病认识的进展,特别是其分子生物学以及全身治疗和放射治疗的作用机制,以及图像引导手术技术的发展,为控制这种迄今为止无法治愈的疾病带来了希望。

相似文献

1
[Glioblastoma].[胶质母细胞瘤]
Rev Med Liege. 2021 May;76(5-6):419-424.
2
Human TERT promoter mutation enables survival advantage from MGMT promoter methylation in IDH1 wild-type primary glioblastoma treated by standard chemoradiotherapy.在经标准放化疗治疗的异柠檬酸脱氢酶1(IDH1)野生型原发性胶质母细胞瘤中,人端粒酶逆转录酶(TERT)启动子突变可使甲基鸟嘌呤-DNA甲基转移酶(MGMT)启动子甲基化带来生存优势。
Neuro Oncol. 2017 Mar 1;19(3):394-404. doi: 10.1093/neuonc/now189.
3
N2M2 (NOA-20) phase I/II trial of molecularly matched targeted therapies plus radiotherapy in patients with newly diagnosed non-MGMT hypermethylated glioblastoma.N2M2(NOA-20)期 I/II 试验:针对新诊断的非 MGMT 高甲基化胶质母细胞瘤患者,采用分子匹配的靶向治疗联合放疗。
Neuro Oncol. 2019 Jan 1;21(1):95-105. doi: 10.1093/neuonc/noy161.
4
Dynamic expression of 11 miRNAs in 83 consecutive primary and corresponding recurrent glioblastoma: correlation to treatment, time to recurrence, overall survival and MGMT methylation status.83例连续原发性及相应复发性胶质母细胞瘤中11种微小RNA的动态表达:与治疗、复发时间、总生存期及O6-甲基鸟嘌呤-DNA甲基转移酶甲基化状态的相关性
Radiol Oncol. 2018 Nov 26;52(4):422-432. doi: 10.2478/raon-2018-0043.
5
O(6) -methylguanine-DNA methyltransferase (MGMT) promoter methylation and low MGMT-encoded protein expression as prognostic markers in glioblastoma patients treated with biodegradable carmustine wafer implants after initial surgery followed by radiotherapy with concomitant and adjuvant temozolomide.O(6)-甲基鸟嘌呤-DNA 甲基转移酶(MGMT)启动子甲基化和低 MGMT 编码蛋白表达作为初始手术后行放疗联合替莫唑胺辅助治疗的胶质母细胞瘤患者的预后标志物,治疗中使用了可生物降解的卡莫司汀植入物。
Cancer. 2012 Sep 15;118(18):4545-54. doi: 10.1002/cncr.27441. Epub 2012 Feb 22.
6
Molecular Evolution of Wild-Type Glioblastomas Treated With Standard of Care Affects Survival and Design of Precision Medicine Trials: A Report From the EORTC 1542 Study.标准治疗下的野生型胶质母细胞瘤的分子进化会影响生存和精准医学试验的设计:来自 EORTC 1542 研究的报告。
J Clin Oncol. 2020 Jan 1;38(1):81-99. doi: 10.1200/JCO.19.00367. Epub 2019 Nov 19.
7
Treatment of Glioblastoma.胶质母细胞瘤的治疗
J Oncol Pract. 2017 Oct;13(10):629-638. doi: 10.1200/JOP.2017.025536.
8
O-methylguanine-DNA methyltransferase promoter methylation and isocitrate dehydrogenase mutation as prognostic factors in a cohort of Saudi patients with glioblastoma.O-甲基鸟嘌呤-DNA甲基转移酶启动子甲基化和异柠檬酸脱氢酶突变作为沙特胶质母细胞瘤患者队列中的预后因素。
Ann Saudi Med. 2019 Nov-Dec;39(6):410-416. doi: 10.5144/0256-4947.2019.410. Epub 2019 Dec 5.
9
Arterial spin labeling perfusion-weighted imaging aids in prediction of molecular biomarkers and survival in glioblastomas.动脉自旋标记灌注加权成像有助于预测胶质母细胞瘤的分子生物标志物和生存。
Eur Radiol. 2020 Feb;30(2):1202-1211. doi: 10.1007/s00330-019-06379-2. Epub 2019 Aug 29.
10
Treatment considerations for MGMT-unmethylated glioblastoma.MGMT 未甲基化胶质母细胞瘤的治疗考虑因素。
Curr Neurol Neurosci Rep. 2015 Jan;15(1):507. doi: 10.1007/s11910-014-0507-z.

引用本文的文献

1
Glioblastoma: A Multidisciplinary Approach to Its Pathophysiology, Treatment, and Innovative Therapeutic Strategies.胶质母细胞瘤:关于其病理生理学、治疗及创新治疗策略的多学科方法
Biomedicines. 2025 Aug 2;13(8):1882. doi: 10.3390/biomedicines13081882.
2
Photodynamic therapy and associated targeting methods for treatment of brain cancer.用于治疗脑癌的光动力疗法及相关靶向方法。
Front Pharmacol. 2023 Sep 28;14:1250699. doi: 10.3389/fphar.2023.1250699. eCollection 2023.
3
Analysis of the key prognostic genes and potential traditional Chinese medicine therapeutic targets in glioblastoma based on bioinformatics and network pharmacology methods.
基于生物信息学和网络药理学方法分析胶质母细胞瘤的关键预后基因及潜在的中药治疗靶点
Transl Cancer Res. 2022 May;11(5):1386-1405. doi: 10.21037/tcr-22-1122.